Encompass Health (EHC) Depreciation & Amortization (CF) (2009 - 2026)

Encompass Health has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $87.3 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 10.23% year-over-year to $87.3 million; the trailing twelve-month figure through Mar 2026 stood at $336.0 million (up 8.91% YoY), and the FY2025 full-year result was $327.9 million, up 9.45% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $87.3 million, up from $86.4 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $87.3 million in Q1 2026, with the low at $57.7 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $72.5 million across 5 years, with a median of $72.6 million in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) fell 7.68% — and 2023, when it advanced 20.0%.
• Encompass Health's Depreciation & Amortization (CF) stood at $63.3 million in 2022, then advanced by 10.74% to $70.1 million in 2023, then advanced by 11.27% to $78.0 million in 2024, then increased by 10.77% to $86.4 million in 2025, then climbed by 1.04% to $87.3 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $87.3 million (Q1 2026), $86.4 million (Q4 2025), and $82.4 million (Q3 2025), per Business Quant data.